This compound is a protected piperazine derivative featuring both tert-butoxycarbonyl (Boc) and benzyloxycarbonyl (Cbz) protecting groups, along with a carboxylic acid functional group. It is commonly supplied as a pharmaceutical intermediate for use in research and manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 129365-23-7
4-[(benzyloxy)carbonyl]-1-[(tert-butoxy)carbonyl]piperazine-2-carboxylic acid
Pharmaceutical intermediate for peptide synthesis
(S)-1-((Benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)piperazine-2-carboxylic acid
Pharmaceutical intermediate for peptide synthesis
(R)-N-4-Boc-N-1-Cbz-2-piperazine carboxylic acid
Pharmaceutical intermediate for API synthesis
N-4-Boc-N-1-Cbz-2-piperazine carboxylic acid
Pharmaceutical intermediate with orthogonal protecting groups
(2S,6S)-17-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-3-one
pharmaceutical intermediate
3-Amino-2,6-dichloro-4-methylpyridine
Pharmaceutical intermediate
((2R,3R,4R)-3-((4-Chlorobenzoyl)oxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl 4-chlorobenzoate
Pharmaceutical intermediate for sofosbuvir
[(2R,3R,4R,5R)-5-BROMO-3-(4-CHLOROBENZOYLOXY)-4-FLUORO-4-METHYLOXOLAN-2-YL]METHYL 4-CHLOROBENZOATE
Pharmaceutical intermediate
1-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenylmethoxycarbonylpiperazine-2-carboxylic acid
SREPAMKILVVDSP-UHFFFAOYSA-N
CC(C)(C)OC(=O)N1CCN(CC1C(=O)O)C(=O)OCC2=CC=CC=C2
—